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Abstract - Dtrerent instruments are used in clinical practice to assess comorbid psychopathology in 
addicted individuals. This study is aimed at comparing two of those instruments. In total, 327 heroin- and 
methadone-addicted individuals were interviewed in three treatment settings and outside treatment. 
Instruments used are the Addiction Severity Index (ASI) and the Composite International Diagnostic 
Interview (CIDI). The former instrument results in a general measure of severity of psychopathology, 
while the latter results in categorical DSM-III-R diagnoses. A comparison of the results show, however, 
that the two types of data do not agree to a large extent. By using the DSM-III-R data as golden standard, 
it appeared that a part of the psychopathology cases was missed out by the ASI severity measures. The 
results, that are especially of interest for clinicians using the ASI, are presented .for various 
disorders. 0 1997 Elsevier Science Inc. 
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INTRODUCTION 
COMORBID OPIATE ADDICTION and psychopathology 
have been the central themes in several recent scientific 
publications. Some authors described prevalences of the 
so-called ‘dual diagnosis’ problems (Abbot, Weller, & 
Walker, 1994; Darke, Wodak, Hall, Heather, & Ward, 
1992; Hendriks, 1990; Raskin & Miller, 1993; Regier et 
al., 1990; Rounsaville, Weissman, Kleber, & Wilber, 
1982; Swift, Williams, Neil1 & Grenyer, 1990). Others 
discussed the causality of these problems (Lehman, My- 
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ers, & Corty, 1989; Lehman, Myers, Thompson, & Corty 
1993; Turnbull & Roszell, 1993). Hypotheses, such as 
the possibility that different drug use patterns result in 
different types of psychopathology, were investigated 
also (Regier et al., 1990). In these publications, the psy- 
chopathology has been assessed with various instru- 
ments. One of these is the Addiction Severity Index 
(Hendriks, Kaplan, Limbeck, & Geerlings, 1989; McLel- 
lan, Luborsky, Woody, & O’Brien, 1980), which is used 
with increasing frequency in treatment programs, scien- 
tific studies, and for registration purposes. An important 
advantage of the AS1 is the multidimensional concept of 
addiction problems. This makes it possible to study prob- 
lems in different aspects of life, including psychiatric 
problems within one instrument. As for addicted individ- 
uals with psychiatric comorbidity, for instance, the AS1 
is capable of describing the nature and extent of drug 
problems as well as psychiatric problems (McLellan et al., 
1983; Rounsaville, Kosten, Weissman, & Kleber, 1986; 
Stoffelmayer, Benishek, Humphreys, Lee, & Mavis, 
1989). Although the AS1 was never meant for screening 
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on psychopathology, it has been used as such in practice 
by clinicians and researchers. 
However, given the complex nature of the comorbid 
psychiatric and addiction problems (Lehman, Myers, 
Dixon, & Johnson, 1994), there is a disadvantage to the 
ASI. The psychiatry section results in a dimensional 
measure, expressing severity that is not specific enough 
to describe the psychiatric problems in terms of a classi- 
fication system, such as for instance categorical DSM- 
Ill-R disorders. Instruments that provide a better distinc- 
tion between symptom level and disorder level on the 
one hand contribute to an improved insight in the prob- 
lem complexity by describing types of psychopathology. 
But, on the other hand, they require considerably more 
interview time, which is often lacking in treatment set- 
tings and research situations. Information about the rela- 
tion between the AS1 psychiatry section and specific psy- 
chiatric disorders may be useful for those clinicians who 
are not able to conduct an elaborate psychiatric inter- 
view. Therefore, the aim of this paper is to describe to 
what extent the psychiatry section of the AS1 reflects 
DSM-III-R disorders, assessed with the Composite Inter- 
national Diagnostic Interview (Robins et al., 1989). An 
earlier study of Hendriks (1990) showed that, compared 
with the psychiatric symptom check list SCL-90 (Dero- 
gatis, 1983) and the Beck Depression Inventory (Beck, 
Ward, Mendelson, Mock, & Erbaugh, 1961) the AS1 was 
the best screening instrument for anxiety-related disor- 
ders and depressive disorders. Among opiate-addicted 
individuals who participated in a residential detoxifica- 
tion program, 8 1% of the psychopathology cases could 
be identified with a severity rating of 5 or higher in the 
psychiatry section of the ASI. In this instance, 55% of the 
cases without psychopathology were correctly identified. 
MATERIALS AND METHODS 
Subjects 
The central topic of this publication is part of a larger 
study in which opiate-addicted individuals in and outside 
of treatment are compared. During a period of about 30 
months in which data were gathered, 327 opiate-addicted 
individuals were interviewed. The respondents had been 
dependent on opiates for at least the past 2 years, which 
is in accordance with DSM-III-R criteria, and they were 
18 years or older. Respondents who stayed in the treat- 
ment setting for less than 2 weeks were excluded from 
the study. Subjects were acquired in four settings. In a 
low-threshold methadone program, 91 respondents were 
selected on consecutive admission; every third respon- 
dent who applied for the program was approached. In a 
clinical detoxification program, 72 respondents who did 
not continue their treatment with a therapeutic commu- 
nity (TC) (detox only) and 77 who did continue their 
treatment in a TC were interviewed. All subjects in treat- 
ment were interviewed at intake and signed a form of 
consent. Interviews were conducted by trained staff of 
the treatment settings. There were regular meetings dur- 
ing which the researcher commented on the interviews. 
83 opiate-addicted individuals without treatment were 
interviewed. They had not received treatment for more 
than 2 weeks over the past 2 years. They were selected 
by means of the snowball sampling method with nomi- 
nee selection (Hendriks, Blanken, & Adriaans, 1992). In 
this method, the interviewed respondent names about six 
other heroin users without treatment contacts. Of these, 
one is randomly selected and interviewed. All subjects 
outside of treatment were paid for their participation. 
The fieldwork was carried out by the researcher and a 
community fieldworker who was trained in interview 
techniques. The nonresponse numbers in the different 
settings were: community: 22% of the users identified by 
the chain referral method could not be located or refused 
to participate and 9% of the approached users did not 
show up at the second or third appointment; methadone: 
26% of the approached users refused participation or did 
not show up; inpatient: 9% of the respondents left the 
setting before the required 2 weeks and, therefore, no 
CID1 interview was recorded. AS1 interviews of 11% of 
the inpatient heroin users could not be retrieved by the 
treatment setting. The sociodemographic characteristics 
of the lost respondents in the treatment settings did not 
differ from those of the interviewed users. 
Procedure 
Two instruments were used. The Dutch version of the 
Addiction Severity Index (ASIR) (Hendriks et al., 1989; 
McLellan et al., 1980) was used to collect information on 
several life aspects. These are physical health, employ- 
ment, alcohol and drug use, legal status, social function- 
ing, and psychiatric problems. Both lifetime and current 
problems are addressed. For every area an overall “se- 
verity rating” was established; this rating was chosen in a 
range from 0 (no problems/no need for help) to 9 (ex- 
treme problems/extreme need for help). Composite scores 
were also computed, based on recent items of the ASIR 
(Hendriks et al., 1989; McLellan et al., 1985). These 
composite scores are considered to be more objective 
than the severity ratings, because the interviewer’s opin- 
ion does not play a role. The Composite International Di- 
agnostic Interview (CIDI) (Robins et al., 1989) was ad- 
ministered to describe the respondents’ psychopathology 
in terms of DSM-III-R disorders. The disorders were 
grouped into three categories that were previously used 
by other researchers (Hendriks, 1990; Limbeek et al., 
1992; Rounsaville et al., 1982). Recent disorders only 
(last 6 months) are presented. Major depression, dys- 
thymia, and manic disorder were united in the category 
“affective disorders.” Generalized anxiety, obsessive- 
compulsive disorder, agoraphobia, and panic disorder to- 
gether constituted the category “anxiety disorders.” So- 
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TABLE 1 
Percentage of Respondents with 0, 1,2, and 3 or More 
Recent Psychiatric Disorders (Measured with CIDI) by 
ASI Psychiatry Rating 
0 1 2 3 or More 
Severity Disorders Disorder Disorders Disorders 
Rating (n = 112) (n = 85) (n = 52) (n = 77) 
24 41% 53% 62% 70% 
25 20% 38% 44% 58% 
26 1% 25% 33% 45% 
cial and simple phobias were left out because too many 
respondents were classified in the anxiety category due 
to only one of these, relatively light, phobias. The third 
category was antisocial personality disorder (ASP). Life- 
time schizophrenic disorders make up the fourth category. 
Data Analysis 
In general, there are two kinds of overall measures in the 
ASI: severity ratings and composite scores. When the 
AS1 is used as a screening instrument to identify addicted 
individuals with psychiatric problems, cut-off points can 
be used to distinguish between respondents with and 
without those problems. The choice of such a cut-off 
point is based more often on intuition than on empirical 
data. To find out to what extent certain psychiatric disor- 
ders were screened, validity measures of sensitivity and 
specificity of the diagnoses were obtained by comparing 
the AS1 psychiatric overall measures at several cut-off 
points with the criterion (CIDI). There could be four pos- 
sible combinations. True-positive (TP) and true-negative 
(TN) classifications occur when the two types of data 
agree, false-positive (FP) and false-negative (FN) classi- 
fications occur when the two types of data disagree. Sen- 
sitivity refers to the percentage of persons with a disease 
and who are classified by the test as having the problems 
(TP/‘TP + IN). Specificity points at the percentage of 
persons without the disease and who were classified by 
the test as not having the problems (TN/FP + TN) 
(Bouter & van Dongen, 1991). 
RESULTS 
The results will be presented in four parts. First, it is de- 
scribed to what extent the ASIR is capable of screening 
individuals who have one or more psychiatric disorders. 
Second, data for categories of psychiatric disorders are 
presented which concern the different levels of severity 
ratings of the ASIR psychiatry section, and, thirdly, data 
for comparable categories that concern the different lev- 
els of composite scores of the psychiatry section. Finally 
it is described to what extent the DSM-III-R disorders are 
screened at ASIR item level. 
Screening Respondents with One or More Disorders 
Of the 99 respondents with a recent anxiety disorder, af- 
fect disorder or schizophrenic disorder, it appeared that 
43% received a severity rating of 6 or higher at the psy- 
chiatry section of the ASIR. For a cut-off point of 5 this 
was 59% and for a cut-off point of 4, 13% of these re- 
spondents were identified. When ASP disorder is in- 
cluded, the number of respondents with a recent disorder 
is 169. At a cut-off point of 6, 33% is screened well. At a 
cut-off point of 5, 50% was identified, and at a cut-off 
level of 4 and higher 66% was identified. Lower cut-off 
points screen worse. Table 1 shows to what extent re- 
spondents with none, one, or more recent psychiatric dis- 
order (excluding ASP disorder) were screened accurately 
by the psychiatry section of the ASIR. That the data of 
this section are not totally compatible with the DSM-III-R 
data becomes clear from these results. Respondents with- 
out a recent psychiatric disorder received severity ratings 
of 4 or 5. A cut-off point of 6 was able to distinguish the 
respondents with a recent disorder from those without. 
For the respondents with 1, 2, or 3 and more disorders it 
appeared that a low cut-off point screened reasonable. 
This improved for respondents with more disorders. 
Severity Ratings 
The results in Table 2 represent the relation between the 
ASIR psychiatry ratings and the CID1 diagnoses. The se- 
verity ratings were divided into three categories (Low, 
Mid, and High), previously used by McLellan et al. 
TABLE 2 
Percentage of Respondents with Pychopathology (Measured with CIDI) by 
ASI Psychiatry Rating (Low, Mid, High) 
Recent CID1 Disorders 
Affective disorder 
Anxiety disorder 
Schizophrenic disorders 
ASP disorder 
ASI-Low 
Rating O-3 
(n = 147) 
9.5% 
23.1% 
1.4% 
26.5% 
ASI-Mid 
Rating 4-6 
(n = 141) 
27.0% 
27.0% 
5.7% 
39.7% 
ASI-High 
Rating 7-9 
(n = 39) 
30.8% 
48.7% 
13.5% 
33.3% 
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TABLE 3 
Affective Disorders, Anxiety Disorders, Schizophrenic Disorders and ASP Disorder (Measured 
with ClDI) by Several Cut-Off Points on Severity Ratings of the ASI Psychiatry Section (N = 327) 
Cut-Off Points 
Affective Disorders 
Rating 2 3 
Rating 2 4 
Rating 2 5 
Rating 2 6 
Anxiety disorders 
Rating 2 3 
Rating 2 4 
Rating 2 5 
Rating 2 6 
Schizophrenic disorders 
Rating 2 3 
Rating 2 4 
Rating 2 5 
Rating 2 6 
ASP disorder 
Rating 2 3 
Rating 2 4 
Rating 2 5 
Rating 2 6 
Sensitivity Specificity 
Correctly 
Identified 
Cases 
86.2 39.7 49% 
76.9 51.1 50% 
60.0 67.9 66% 
40.0 79.4 66% 
79.2 36.9 44% 
66.0 47.4 51% 
58.5 66.1 65% 
43.4 78.8 73% 
86.6 35.2 38% 
86.6 46.8 49% 
66.7 63.5 64% 
60.0 73.5 76% 
73.1 38.4 49% 
63.9 38.4 53% 
46.3 66.4 58% 
26.9 76.8 58% 
(1983) and Hendriks (1990). It was expected that the per- 
centage of respondents with a particular disorder would 
increase from the low to the middle group and from the 
middle to the high group. It emerged that this was true 
with respect to anxiety disorders and schizophrenia, but 
not with respect to affective disorders and ASP disor- 
ders. The number of respondents with an affective disor- 
der in the middle group was 27.0%, which was not very 
different from the 30.8% of the high group. For ASP dis- 
orders the number of respondents with this disorder was 
comparable across all three ASIR categories. This reflects 
the different character of this Axis II (personality) disor- 
der compared to the other Axis I disorders, which are 
better reflected in the severity ratings. 
Table 3 describes to what extent affective, anxiety, 
schizophrenic disorders and ASP disorder categories (CIDI) 
were identified correctly at several cut-off points of the 
ASIR‘s psychiatric severity rating. Of the four categories, 
ASP disorder appeared to be identified worse. At a cut- 
off score of 5, 58% of the cases were well identified, 
while the other categories scored about 65% at this point. 
Composite Scores 
In order to describe the relation between the ASI@ com- 
posite scores and CID1 diagnoses, Table 4 represents 
percentages of users across the different ASI@ categories 
with a low, middle, or high composite score. The three 
categories of composite scores have been formed by cal- 
culating the mean (M = 0.24), ? 1 standard deviation 
(SD = 0.23). This procedure was used previously by 
McLellan et al. (1983) and Stoffelmayer et al. (1989). 
Because the composite scores range from 0 (no prob- 
lems) to 1 (severe problems) it was expected that the high 
category would contain the largest number of respon- 
dents with a particular disorder. However, it appeared 
that the middle group consisted of the largest number of 
TABLE 4 
Percentage of Respondents with Psychopathology (CIDI) by Category of ASI Composite Score 
(Low, Mid, High) 
Recent CID1 
Disorders 
Affective disorder 
Anxiety disorder 
Schizophrenic disorders 
ASP disorder 
Low Score Mid Score 
o-0.01 0.01-0.47 
(n= 111) (n = 154) 
12.9% 50.0% 
13.5% 46.2% 
13.3% 66.7% 
20.0% 62.9% 
High Score 
2 0.47 
(n = 59) 
37.1% 
40.4% 
20.0% 
17.5% 
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respondents who suffered from recent disorders in all 
four categories. This might be a result of the composite 
score being based on only the recent items of the ASIR, 
whereas the severity rating includes past (lifetime) psy- 
chiatric symptoms as well. Indeed, further analyses 
showed that the lifetime average number of DSM-III-R 
disorders was significantly larger in the high group 
(2.83) compared to the middle group (2.18) and the low 
group (1.33) (p = 0.00). This indicates that long-term 
psychiatric information plays an important role in the as- 
sessment of the psychiatric severity of psychiatric prob- 
lems with the ASI@. 
123) and 74.3% of respondents without recent anxiety 
disorders. 
CONCLUSION AND DISCUSSION 
Table 5 represents the results of screening CID1 disor- 
ders at three cut-off points. When the data were cut off 
above the mean, respondents with affective disorders 
were identified best of all (64.3%), followed by ASP dis- 
order (60.1%) anxiety disorders (58.1%) and lifetime 
schizophrenic disorders (54.7%). However, these per- 
centages show that there are no major differences be- 
tween the various disorders. 
Finally, some comparisons were made at item level of 
the ASIR. Of the respondents with a lifelong major de- 
pression or dysthymia (N = 95), 81.3% was screened by 
the ASIR question of whether they had ever been de- 
pressed, while 47.2% of respondents without the disorder 
were correctly classified. Of the respondents with a re- 
cent depressive disorder on the CID1 (N = 61) 57.4% 
was identified by the ASIR question of whether they had 
been depressed in the past month, whereas 71.6% with- 
out depressive disorders scored negatively at the ASIR 
depression question. Of the lifetime anxiety disorders 
(N = 181), 65.7% of respondents were correctly identi- 
fied by the ASIR, and 58.1% of respondents without the 
disorder were screened correctly. The ASIR recognized 
46.3% of respondents with recent anxiety disorders (N = 
A limitation of this study is that the CID1 diagnoses, 
which are considered the “golden standard” in this com- 
parison, are also assessments with a better or worse sen- 
sitivity and specificity, A comparison with, for instance, 
clinically assessed disorders might give an indication of 
the quality of the CID1 results, but even these clinically 
assessed disorders are not watertight. For example, Kranz- 
ler et al. (1995) compared the validity of psychiatric di- 
agnoses that were obtained by a clinical interview (SCID) 
conducted by a Master’s level clinician with the validity 
of diagnoses that were the result of a nonclinician con- 
ducting a-standardized interview. They concluded that 
the psychiatric diagnosis in substance abuse patients may 
be improved by the addition of elements of structured in- 
terviews to the clinician’s usual assessment. For the 
CIDI, several publications showed good validity of al- 
most all diagnoses except for psychotic disorder 
(Farmer, Katz, McGuffin, & Bebbington, 1987; Janca, 
Robins, Cottler, & Early, 1992; Semler, 1989; Sprengler 
& Wittchen, 1989). 
Furthermore, the reliability of the results in this study 
might be limited because data are based on retrospective 
self-reports of the respondents who were often under the 
influence of drugs. During the fieldwork, respondents 
suffering heavy withdrawal symptoms or strong intoxi- 
cation were not interviewed, but in those cases the ap- 
pointment was rearranged for another time. We expect 
the chances of deliberately falsified answers to be small, 
because there were no financial or other consequences 
attached to the answers. 
TABLE 5 
Affective Disorders, Anxiety Disorders, Schizophrenic Disorders and ASP Disorder by 
3 Cut-Off Points on Composite Scores (N = 327) 
Cut-off Points 
Affective disorders 
Low (20.01) 
Mid (~0.24) 
High (~0.47) 
Anxiety disorders 
Low (20.01) 
Mid (~0.24) 
High (~0.47) 
Schizophrenic disorders 
Low (20.01) 
Mid (~0.24) 
High (~0.47) 
ASP disorder 
Low (20.01) 
Mid (~0.24) 
High (~0.47) 
Sensitivity Specificity 
87.1 39.6 
74.2 61.9 
38.7 86.9 
86.5 38.5 
59.6 57.8 
40.4 86.3 
86.7 35.5 
46.7 55.0 
20.0 82.1 
80.0 42.9 
58.1 61.9 
18.1 82.9 
Correctly 
Identified 
Cases 
48.8% 
64.3% 
77.6% 
46.3% 
58.1% 
78.9% 
37.9% 
54.7% 
79.2% 
55.2% 
60.1% 
61 .3% 
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The present results indicate that the ASIR psychiatry 
section detects part of the psychopathology cases, but 
also misses out on a substantial number. For instance, at 
item level, 18.7% of respondents with lifetime depres- 
sion were missed out and 34.3% of respondents with life- 
time anxiety disorders. Also, at the severity rating level, 
about 35% of respondents with anxiety, affective, or 
schizophrenic disorders were missed out at a cut-off 
level of 5. The detection of ASP disorder was worse. The 
number of respondents in the group with middle severity 
ratings (4-6) that reported ASP disorder was larger than 
in the high group (7-9). At the various cut-off levels the 
percentage of correctly identified cases with respect to 
ASP disorder also remained low. This indicates that Axis 
II personality disorders such as ASP are of a different na- 
ture when compared to the Axis I disorders. 
One reason for these differences between the instru- 
ments is that in a structured psychiatric interview, all 
DSM-III-R symptoms of a disorder are investigated, 
which results in a categorical diagnoses at disorder level. 
For each symptom it is checked whether it is severe 
enough, whether it results from a physical illness or from 
substance use, whereas the ASIR psychiatry section mea- 
sures more at symptom level. It is less extensive and it 
integrates the information about different types of psy- 
chiatric symptoms into a dimensional measure to indi- 
cate the severity of the psychiatric problems, regardless 
of the type of psychopathology. The latter screens only 
part of the psychopathology cases. Another explanation 
for the differences that were found between the instru- 
ments could be the conclusion of Raskin and Miller 
(1993) that psychiatric symptoms that are common in ac- 
tive addiction are mainly symptoms that generally disap- 
pear within weeks or months of treatment for addiction. 
Because the CID1 results are described at disorder level, 
many symptoms might not pass this threshold of the dis- 
order level, while these are screened by the ASIR. A 
comparison of the sensitivity and specificity of the ASIR 
psychiatry severity rating and the psychiatric composite 
score shows that the severity rating approaches the recent 
CID1 diagnoses better than the composite scores. When 
the scores were compared across three groups (low, mid, 
high), it turned out that not the highest group but the 
middle group consisted of the largest number of respon- 
dents with psychiatric disorders. This indicates that the 
inclusion of lifetime items of the ASIR psychiatry scale, 
as is the case with severity ratings, improves comparabil- 
ity with the CID1 results. 
What is the best cut-off point to screen a particular 
type of psychopathology depends on several factors, such 
as the nature of the disease, the available money, and the 
consequences for the people undergoing the test-all play 
a part. For example, a high sensitivity is required with re- 
gard to diseases that would deteriorate without treatment, 
but that can be successfully treated if they are detected in 
time. A sensitive test is also useful in order to eliminate 
people without diseases at the start of the diagnostic pro- 
cess. A negative consequence of choosing a high sensi- 
tivity is that persons are sometimes labelled as psychiat- 
ric (false positives) without reason. This may lead to 
emotional damage or medical overconsumption. (Bouter 
& van Dongen, 1991). The current study considers men- 
tal disorders. The negative effect of severe psychiatric 
comorbidity on the prognosis for treatment (McLellan et 
al., 1983; Rounsaville, Dolinsky, Babor, & Meyer, 1987) 
underlines the importance of thoroughly screening these 
disorders. Therefore, a cut-off point with high sensitivity 
seems most appropriate. Yet another reason for choosing a 
high sensitivity is that the nature of the psychopathology in 
opiate-addicted individuals might not be apparent at first 
sight. When screening takes place at the moment of intake, 
the chances are that psychological symptoms dissolve dur- 
ing the first weeks of treatment. Therefore, it seems more 
appropriate to choose for a large number of false positives 
in order to end up with the true psychiatric disorders. 
Implications of the results are that the ASIR psychiatry 
section should only be used very carefully for assessment 
of psychopathology in opiate-addicted individuals. Be- 
cause of the low agreement between ASIR data and 
DSM-III-R disorders, we advise using the ASIR psychia- 
try section for the first step in a screening process only. 
The next step would be a clinician’s opinion or a more 
extensive instrument to assess psychopathology. Unfor- 
tunately, both take extra time, which might not be avail- 
able. If this is the case, a relatively low cut-off point, say 
four, should be used in order not to miss out too many 
addicted individuals with a disorder. The consequence of 
this method is that the extra number of false positives 
that are necessary to find the number of true positives re- 
quires additional financial resources. Also, with respect 
to the rather large number of false positives, especially 
those in treatment, it is important not to label the client as 
“psychiatric” based on ASIR information alone. 
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